Following the successful implementation of ClinSpark® at the Phase I unit of a top-10 biopharmaceutical company in Europe, the first study database was locked where the entire trial was conducted within the system.

Grafton, WI March 11, 2019 – Foundry Health is proud to announce the release of version 1.4 of its Phase I software platform ClinSpark®. This new version contains many significant improvements over its already feature-rich predecessor. Major improvements have been made in the areas of Study Subject management, ECG review and Informed Consent procedures. Connectivity enhancements have been made benefiting safety lab interfaces and a connection has been established with Verified Clinical Trials to check for potential duplicate subject enrollments.

The global research subject duplicate enrollment prevention solution Verified Clinical Trials (VCT) and Foundry Health’s eSource and phase I automation platform ClinSpark® are now electronically connected. The integration greatly simplifies the process for site users to check for duplicate subject enrollments and several other protocol violations.